Microbial transformation of ginsenoside-Rg1 by Absidia coerulea and the reversal activity of the metabolites towards multi-drug resistant tumor cells

被引:31
作者
Liu, Xin
Qiao, Lirui
Xie, Dan
Zhang, Yi
Zou, Jianhua
Chen, Xiaoguang
Dai, Jungui [1 ]
机构
[1] Chinese Acad Med Sci, Inst Mat Med, Beijing 100050, Peoples R China
关键词
Microbial transformation; Ginsenoside-Rg(1); Absidia coerulea AS 3.2462; Dehydrogenation; Hydroxylation; Tumor MDR reversal activity; P-GLYCOPROTEIN; PROTOPANAXATRIOL;
D O I
10.1016/j.fitote.2011.09.001
中图分类号
R914 [药物化学];
学科分类号
100705 [微生物与生化药学];
摘要
Biotransformation of ginsenoside-Rg(1) (1) by the fungus Absidia coerulea AS 3.2462 yielded five metabolites (2-6). On the basis of spectroscopic data analyses, the metabolites were identified as ginsenoside-F-1 (2), 6 alpha,12 beta-dihydroxydammar-3-one-20(S)-O-beta-D-glucopyranoside (3), 3-oxo-20(S)-protopanaxatriol (4), 3-oxo-7 beta-hydroxy-20(S)-protopanaxatriol (5), and 3-oxo-7 beta,15 alpha-dihydroxy-20(S)-protopanaxatriol (6), respectively. Among them, 5 and 6 are new compounds. These results indicated that Absidia coerulea AS 3.2462 could catalyze the specific C-3 dehydrogenation of derivatives of ginsenoside-Rg(1), as well as hydroxylation at the 7 beta and 15 alpha positions. Metabolites 2,4 and 5 exhibited moderate reversal activity towards A549/taxol MDR tumor cells in vitro. (C) 2011 Elsevier B.V. All rights reserved.
引用
收藏
页码:1313 / 1317
页数:5
相关论文
共 19 条
[1]
Reversal of P-glycoprotein-mediated multidrug resistance by protopanaxatriol ginsenosides from Korean red ginseng [J].
Choi, CH ;
Kang, G ;
Min, YD .
PLANTA MEDICA, 2003, 69 (03) :235-240
[2]
FUJIOKA T, 1987, CHEM PHARM BULL, V35, P3870
[3]
RAPID COLORMETRIC ASSAY FOR CELL VIABILITY - APPLICATION TO THE QUANTITATION OF CYTO-TOXIC AND GROWTH INHIBITORY LYMPHOKINES [J].
GREEN, LM ;
READE, JL ;
WARE, CF .
JOURNAL OF IMMUNOLOGICAL METHODS, 1984, 70 (02) :257-268
[4]
Huang W, 2005, WO, Patent No. [2005/040189, 2005040189]
[5]
Metabolites of ginsenosides as novel BCRP inhibitors [J].
Jin, g Jin ;
Shahi, Sanjay ;
Kang, Hee Kyoung ;
van Veen, Hendrik W. ;
Fan, Tai-Ping .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2006, 345 (04) :1308-1314
[6]
Ginsenoside F1 production from ginsenoside Rg1 by a purified β-glucosidase from Fusarium moniliforme var. subglutinans [J].
Kim, Yeong-Su ;
Yoo, Mi-Hyun ;
Lee, Gi-Woong ;
Choi, Jin-Geun ;
Kim, Kyoung-Rok ;
Oh, Deok-Kun .
BIOTECHNOLOGY LETTERS, 2011, 33 (12) :2457-2461
[7]
Enzymatic preparation of ginsenosides Rg2, Rh1, and F11) [J].
Ko, SR ;
Choi, KJ ;
Suzuki, K ;
Suzuki, Y .
CHEMICAL & PHARMACEUTICAL BULLETIN, 2003, 51 (04) :404-408
[8]
Microbial deglycosylation and ketonization of ginsenosides Rg1 and Rb1 by Fusarium oxysporum [J].
Liu, Xin ;
Qiao, Li-Rui ;
Xie, Dan ;
Dai, Jun-Gui .
JOURNAL OF ASIAN NATURAL PRODUCTS RESEARCH, 2011, 13 (07) :652-658
[9]
Mistry P, 2001, CANCER RES, V61, P749
[10]
Biotransformation of ginsenosides by hydrolyzing the sugar moieties of ginsenosides using microbial glycosidases [J].
Park, Chang-Su ;
Yoo, Mi-Hyun ;
Noh, Kyeong-Hwan ;
Oh, Deok-Kun .
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY, 2010, 87 (01) :9-19